3 Results for "

ER degrader13

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "ER degrader13" in MCE Product Catalog:

Cat. No.: HY-176956
CAS No.: 2839847-93-5
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

ER degrader 13 (Compound 37) is an estrogen receptor (ER) degrader. ER degrader 13 has a significant inhibitory effect on the proliferation of ER-positive breast cancer MCF-7 cells .
loading...
    loading...
Cat. No.: HY-172937
CAS No.: 3070968-56-5
ERα degrader 13 is an orally active, methylene blue-Raloxifene (HY-13738) conjugated photoactivatable ERα degrader with a Kd value of 27.1 nM. Upon irradiation at 660 nm, ERα degrader 13 generates ROS and heat near the ligand-binding domain of ERα, triggering oxidation, residue unfolding, and ERα degradation via the ubiquitin-proteasome system. ERα degrader 13 inhibits cancer cell proliferation and induces tumor regression in breast cancer xenograft models. ERα degrader 13 can be used in breast cancer-related research .
loading...
    loading...
Cat. No.: HY-178961
Research Areas:  

Cancer

PROTAC ERα Degrader-13 is an orally active PROTAC molecule that efficiently and selectively degrades ERα (DC50 = 3.78 nM). PROTAC ERα Degrader-13 has the characteristics of strong anti proliferation (IC50 = 0.6 nM), induction of apoptosis, and overcoming drug resistance in MCF-7 cells. PROTAC ERα Degrader-13 has good safety and no significant organ toxicity. PROTAC ERα Degrader-13 can be used for cancer research .
loading...
    loading...